The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
Alejandro Vázquez‐Martín(Latvian Biomedical Research and Study Centre), Javier A. Menéndez(Institut Català d'Oncologia)
Cited by 251
Related Papers
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
|PLoS ONE|2009|245
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
|BMC Cancer|2007|191
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
|European Journal of Cancer|2001|145
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
|Frontiers in Endocrinology|2018|122